Definitive Healthcare (DH) Stock Price, News & Analysis

Company Overview

Definitive Healthcare (NASDAQ:DH) is a leading provider of data, analytics and workflow solutions for the healthcare industry. The company combines proprietary data collection and curation with advanced analytics to offer comprehensive insights into providers, organizations, procedures, and relationships across the continuum of care. Its solutions empower life sciences companies, medical device manufacturers, healthcare service providers and payers to identify market opportunities, improve sales and marketing effectiveness, and support clinical and operational decision-making.

The core of Definitive Healthcare’s offering is its cloud-based platform, which integrates data on physicians, hospitals, health systems, payers and post-acute care facilities. Clients can access detailed profiles, referral and affiliation patterns, quality metrics, and financial indicators. The platform’s configurable dashboards, custom reporting tools and application programming interfaces (APIs) enable organizations to embed insights directly into their existing workflows and CRM systems, accelerating go-to-market strategies and optimizing resource allocation.

Since its founding in 2011, Definitive Healthcare has expanded through both organic growth and strategic acquisitions. The company has continually enhanced its datasets and analytics capabilities, investing in machine learning and natural language processing to extract meaningful trends from clinical registries, claims data, clinical trials and news sources. In February 2021, Definitive Healthcare completed its initial public offering, positioning it to further scale its operations and broaden its global footprint.

Headquartered in Nashville, Tennessee, Definitive Healthcare also maintains offices in key international markets including London, Dublin and Singapore. Under the leadership of CEO and co-founder Daniel Michelson, the company employs a multidisciplinary team of data scientists, healthcare experts and software engineers. This collective expertise supports an expanding customer base across North America, Europe and the Asia-Pacific region, helping organizations navigate an increasingly complex healthcare landscape.

Key Stats

• Today's Range: $4.04 to $4.23
• 50-Day Range: $2.68 to $4.17
• 52-Week Range: $2.15 to $6.16
• Volume: 461,683 shs
• Average Volume: 805,560 shs
• Market Capitalization: $619.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.10
• Consensus Rating: Reduce

Definitive Healthcare Stock Analysis - MarketRank™

Definitive Healthcare scored higher than 14% of companies evaluated by MarketBeat, and ranked 529th out of 655 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Definitive Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.90, and is based on 1 buy rating, 7 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Definitive Healthcare has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: -12.50%

Earnings Growth

Earnings for Definitive Healthcare are expected to decrease by -12.50% in the coming year, from $0.16 to $0.14 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Definitive Healthcare is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Definitive Healthcare is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Definitive Healthcare has a PEG Ratio of 7.01. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Definitive Healthcare has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.30% of the float of Definitive Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Definitive Healthcare has a short interest ratio ("days to cover") of 5.3.

Change versus previous month

Short interest in Definitive Healthcare has recently increased by 19.95%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Definitive Healthcare does not currently pay a dividend.

Dividend Growth

Definitive Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

12.30% of the float of Definitive Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Definitive Healthcare has a short interest ratio ("days to cover") of 5.3.

Change versus previous month

Short interest in Definitive Healthcare has recently increased by 19.95%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Definitive Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.84% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DH Stock Analysis - Frequently Asked Questions

How have DH shares performed this year?

Definitive Healthcare's stock was trading at $4.11 on January 1st, 2025. Since then, DH stock has increased by 1.5% and is now trading at $4.17.

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) released its earnings results on Thursday, May, 8th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. The business's revenue was down 6.8% on a year-over-year basis.
Read the conference call transcript.

When did Definitive Healthcare IPO?

Definitive Healthcare (DH) raised $350 million in an IPO on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Definitive Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Definitive Healthcare investors own include AU Optronics (AUOTY), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Triple Flag Precious Metals (TFPM) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 7/09/2025
• Next Earnings (Estimated): 8/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: INTERNET SOFTWARE
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:DH
• CIK: 1861795
• Web: www.definitivehc.com
• Phone: 508-720-4224
• Fax: N/A
• Employees: 970
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Definitive Healthcare: $5.10
• High Price Target: $7.50
• Low Price Target: $3.00
• Potential Upside/Downside: +22.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.90
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): ($4.39)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 26.06
• P/E Growth: 7.01
• Net Income: -$413.12 million
• Net Margins: -206.05%
• Pretax Margin: -317.14%
• Return on Equity: 3.69%
• Return on Assets: 2.15%

Debt

• Debt-to-Equity Ratio: 0.37
• Current Ratio: 1.75
• Quick Ratio: 1.75

Sales & Book Value

• Annual Sales: $252.20 million
• Price / Sales: 2.46
• Cash Flow: $5.42 per share
• Price / Cash Flow: 0.77
• Book Value: $4.09 per share
• Price / Book: 1.02

Miscellaneous

• Outstanding Shares: 148,640,000
• Free Float: 126,584,000
• Market Cap: $619.83 million
• Optionable: Not Optionable
• Beta: 1.64